Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier
Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier
View: Text | PDF
Research Article Immunology

Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation

  • Text
  • PDF
Abstract

Some effector CD4+ T cell subsets display cytotoxic activity, thus breaking the functional dichotomy of CD4+ helper and CD8+ cytotoxic T lymphocytes. However, molecular mechanisms regulating CD4+ cytotoxic T lymphocyte (CD4+ CTL) differentiation are poorly understood. Here we show that levels of histone deacetylases 1 and 2 (HDAC1-HDAC2) are key determinants of CD4+ CTL differentiation. Deletions of both Hdac1 and 1 Hdac2 alleles (HDAC1cKO-HDAC2HET) in CD4+ T cells induced a T helper cytotoxic program that was controlled by IFN-γ–JAK1/2–STAT1 signaling. In vitro, activated HDAC1cKO-HDAC2HET CD4+ T cells acquired cytolytic activity and displayed enrichment of gene signatures characteristic of effector CD8+ T cells and human CD4+ CTLs. In vivo, murine cytomegalovirus–infected HDAC1cKO-HDAC2HET mice displayed a stronger induction of CD4+ CTL features compared with infected WT mice. Finally, murine and human CD4+ T cells treated with short-chain fatty acids, which are commensal-produced metabolites acting as HDAC inhibitors, upregulated CTL genes. Our data demonstrate that HDAC1-HDAC2 restrain CD4+ CTL differentiation. Thus, HDAC1-HDAC2 might be targets for the therapeutic induction of CD4+ CTLs.

Authors

Teresa Preglej, Patricia Hamminger, Maik Luu, Tanja Bulat, Liisa Andersen, Lisa Göschl, Valentina Stolz, Ramona Rica, Lisa Sandner, Darina Waltenberger, Roland Tschismarov, Thomas Faux, Thorina Boenke, Asta Laiho, Laura L. Elo, Shinya Sakaguchi, Günter Steiner, Thomas Decker, Barbara Bohle, Alexander Visekruna, Christoph Bock, Birgit Strobl, Christian Seiser, Nicole Boucheron, Wilfried Ellmeier

×

Figure 1

HDAC1/HDAC2 dosage–dependent upregulation of CD8 lineage factors in CD4+ T cells.

Options: View larger image (or click on image) Download as PowerPoint
HDAC1/HDAC2 dosage–dependent upregulation of CD8 lineage factors in CD4+...
(A) Overview of the different mouse strains used for the experiments. The crossed arrows indicate deleted Hdac1 and Hdac2 alleles. (B) Histograms showing HDAC2 and HDAC1 expression levels in TCRβ+CD4+ splenocytes isolated from WT, HDAC1cKO, HDAC2cKO, HDAC1HET-HDAC2cKO, and HDAC1cKO-HDAC2HET mice. (C) Flow cytometry analyses showing CD4, IFN-γ, granzyme B (GzmB), and EOMES expression in WT, HDAC1cKO, HDAC2cKO, HDAC1HET-HDAC2cKO, and HDAC1cKO-HDAC2HET CD4+ T cells and WT CD8+ T cells activated with anti-CD3 and anti-CD28 for 3 days in the presence of IL-2. (D) Summary diagrams showing the percentages of IFN-γ+, granzyme B+, T-bet+, and EOMES+ cells of the indicated genotype as described in C and D. For CD8α+, WT MFI levels were set as 1, and relative MFI levels in HDAC1cKO, HDAC2cKO, HDAC1HET-HDAC2cKO, and HDAC1cKO-HDAC2HET CD4+ and WT CD8+ T cells are shown. Each symbol indicates 1 independent biological sample. Horizontal bars indicate the mean. *P < 0.05, **P < 0.01, and ***P < 0.001, 1-way ANOVA analysis followed by Tukey’s multiple-comparisons test (CD8+ WT is shown as control and was not included in the statistical analysis). (E) Histograms showing T-bet and CD8 expression in WT, HDAC1cKO, HDAC2cKO, HDAC1HET-HDAC2cKO, and HDAC1cKO-HDAC2HET CD4+ and WT CD8+ T cells activated as described in C. (B, C, and E) Numbers indicate the percentage of cells in the respective quadrants or gates or, as indicated, the MFI. (B and E) The dotted vertical lines indicate the peak of the WT histogram (for MFI), while the vertical solid line indicates the gating region for the percentage of cells. Data are representative (B, C, and E) or show a summary (D) of at least 7 (B) or 6 (C, D, and E) mice that were analyzed in at least 3 (B) or 4 (C, D, and E) independent experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts